• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从癌前病变到浸润性肺腺癌的 DNA 甲基组演变。

Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas.

机构信息

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

出版信息

Nat Commun. 2021 Jan 29;12(1):687. doi: 10.1038/s41467-021-20907-z.

DOI:10.1038/s41467-021-20907-z
PMID:33514726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7846738/
Abstract

The evolution of DNA methylome and methylation intra-tumor heterogeneity (ITH) during early carcinogenesis of lung adenocarcinoma has not been systematically studied. We perform reduced representation bisulfite sequencing of invasive lung adenocarcinoma and its precursors, atypical adenomatous hyperplasia, adenocarcinoma in situ and minimally invasive adenocarcinoma. We observe gradual increase of methylation aberrations and significantly higher level of methylation ITH in later-stage lesions. The phylogenetic patterns inferred from methylation aberrations resemble those based on somatic mutations suggesting parallel methylation and genetic evolution. De-convolution reveal higher ratio of T regulatory cells (Tregs) versus CD8 + T cells in later-stage diseases, implying progressive immunosuppression with neoplastic progression. Furthermore, increased global hypomethylation is associated with higher mutation burden, copy number variation burden and AI burden as well as higher Treg/CD8 ratio, highlighting the potential impact of methylation on chromosomal instability, mutagenesis and tumor immune microenvironment during early carcinogenesis of lung adenocarcinomas.

摘要

在肺腺癌早期癌变过程中,DNA 甲基组和甲基化肿瘤内异质性(ITH)的演变尚未得到系统研究。我们对浸润性肺腺癌及其前体,非典型腺瘤性增生、原位腺癌和微浸润性腺癌进行了简化代表性重亚硫酸盐测序。我们观察到甲基化异常逐渐增加,晚期病变的甲基化 ITH 水平显著升高。基于甲基化异常推断的系统发育模式类似于基于体细胞突变的模式,提示甲基化和遗传进化并行。去卷积显示,晚期疾病中 T 调节细胞(Tregs)与 CD8+T 细胞的比例更高,这意味着随着肿瘤的进展,免疫抑制逐渐增强。此外,全基因组低甲基化与更高的突变负担、拷贝数变异负担和 AI 负担以及更高的 Treg/CD8 比例相关,这突出了甲基化在肺腺癌早期癌变过程中对染色体不稳定性、致突变性和肿瘤免疫微环境的潜在影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/a298cec7ee8d/41467_2021_20907_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/f93d91b4935e/41467_2021_20907_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/bca1cd18c2fe/41467_2021_20907_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/413acd182b8f/41467_2021_20907_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/4e11f5af52d5/41467_2021_20907_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/60f3a2898ed7/41467_2021_20907_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/fac0bf0cd6ff/41467_2021_20907_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/a298cec7ee8d/41467_2021_20907_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/f93d91b4935e/41467_2021_20907_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/bca1cd18c2fe/41467_2021_20907_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/413acd182b8f/41467_2021_20907_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/4e11f5af52d5/41467_2021_20907_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/60f3a2898ed7/41467_2021_20907_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/fac0bf0cd6ff/41467_2021_20907_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d3/7846738/a298cec7ee8d/41467_2021_20907_Fig7_HTML.jpg

相似文献

1
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas.从癌前病变到浸润性肺腺癌的 DNA 甲基组演变。
Nat Commun. 2021 Jan 29;12(1):687. doi: 10.1038/s41467-021-20907-z.
2
Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.从癌前病变到浸润性肺腺癌的免疫进化及其潜在分子特征。
Nat Commun. 2021 May 11;12(1):2722. doi: 10.1038/s41467-021-22890-x.
3
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.多区域外显子组测序揭示了从癌前病变到肺腺癌的基因组进化。
Nat Commun. 2019 Jul 5;10(1):2978. doi: 10.1038/s41467-019-10877-8.
4
Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.启动子CpG岛高甲基化和重复DNA低甲基化在Ⅰ期肺腺癌中的预后意义
Virchows Arch. 2015 Jun;466(6):675-83. doi: 10.1007/s00428-015-1749-0. Epub 2015 Mar 13.
5
DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.非典型腺瘤样增生、原位腺癌和肺腺癌中的 DNA 甲基化变化。
PLoS One. 2011;6(6):e21443. doi: 10.1371/journal.pone.0021443. Epub 2011 Jun 23.
6
DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas.ZNF132基因的DNA高甲基化参与了“全阴性”型肺腺癌的临床病理侵袭性。
Carcinogenesis. 2021 Feb 25;42(2):169-179. doi: 10.1093/carcin/bgaa115.
7
Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.肺的癌前非典型腺瘤样增生中等位基因失衡的基因组景观。
EBioMedicine. 2019 Apr;42:296-303. doi: 10.1016/j.ebiom.2019.03.020. Epub 2019 Mar 21.
8
DNA methylation profile during multistage progression of pulmonary adenocarcinomas.肺腺癌多阶段进展过程中的 DNA 甲基化谱。
Virchows Arch. 2011 Aug;459(2):201-11. doi: 10.1007/s00428-011-1079-9. Epub 2011 Apr 15.
9
DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.与肺腺癌复发相关的癌前阶段的 DNA 甲基化谱。
PLoS One. 2013;8(3):e59444. doi: 10.1371/journal.pone.0059444. Epub 2013 Mar 27.
10
Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.肿瘤内遗传和表观遗传异质性影响肺腺癌的预后。
Nat Commun. 2020 May 18;11(1):2459. doi: 10.1038/s41467-020-16295-5.

引用本文的文献

1
Genome-wide DNA methylation profiles of colorectal tumors in Lynch syndrome and familial adenomatous polyposis.林奇综合征和家族性腺瘤性息肉病中结直肠肿瘤的全基因组DNA甲基化谱。
Clin Epigenetics. 2025 Aug 2;17(1):137. doi: 10.1186/s13148-025-01940-x.
2
Radiographic ground-glass nodules predict less aggressive features and favorable immune landscapes in early lung adenocarcinoma and its precursors.影像学上的磨玻璃结节提示早期肺腺癌及其前驱病变具有侵袭性较低的特征和良好的免疫格局。
Transl Lung Cancer Res. 2025 Jun 30;14(6):2089-2099. doi: 10.21037/tlcr-2025-231. Epub 2025 Jun 23.
3
Deciphering the transcriptional regulatory network driving lung adenocarcinoma progression.

本文引用的文献

1
Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.从癌前病变到浸润性肺腺癌的免疫进化及其潜在分子特征。
Nat Commun. 2021 May 11;12(1):2722. doi: 10.1038/s41467-021-22890-x.
2
Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.肿瘤内遗传和表观遗传异质性影响肺腺癌的预后。
Nat Commun. 2020 May 18;11(1):2459. doi: 10.1038/s41467-020-16295-5.
3
ImmuCellAI: A Unique Method for Comprehensive T-Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy.
解析驱动肺腺癌进展的转录调控网络。
Med Oncol. 2025 Jul 14;42(8):330. doi: 10.1007/s12032-025-02887-y.
4
Methylation aberrations and genomic instability synergistically drive the evolution of intrahepatic cholangiocarcinoma.甲基化异常与基因组不稳定性协同驱动肝内胆管癌的进展。
Epigenomics. 2025 Jul;17(10):661-674. doi: 10.1080/17501911.2025.2518919. Epub 2025 Jun 17.
5
Promises and pitfalls of multi-cancer early detection using liquid biopsy tests.使用液体活检检测进行多癌早期检测的前景与陷阱
Nat Rev Clin Oncol. 2025 Jun 13. doi: 10.1038/s41571-025-01033-x.
6
The current and emerging immunotherapy paradigm in small-cell lung cancer.小细胞肺癌当前及新出现的免疫治疗模式
Nat Cancer. 2025 Jun 5. doi: 10.1038/s43018-025-00992-5.
7
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLC.2025年肺癌基础与转化研究进展——聚焦非小细胞肺癌的综述与展望
J Thorac Oncol. 2025 Jun 3. doi: 10.1016/j.jtho.2025.05.024.
8
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception.人类和小鼠肺腺癌前体的空间和多组学分析揭示TIM-3是癌前病变拦截的潜在靶点。
Cancer Cell. 2025 Jun 9;43(6):1125-1140.e10. doi: 10.1016/j.ccell.2025.04.003. Epub 2025 May 8.
9
The Current Roadmap of Lung Cancer Biology, Genomics and Racial Disparity.肺癌生物学、基因组学与种族差异的当前路线图
Int J Mol Sci. 2025 Apr 17;26(8):3818. doi: 10.3390/ijms26083818.
10
Use of DNA methylation patterns for early detection and management of lung cancer: Are we there yet?利用DNA甲基化模式进行肺癌的早期检测与管理:我们做到了吗?
Oncol Res. 2025 Mar 19;33(4):781-793. doi: 10.32604/or.2024.057231. eCollection 2025.
免疫细胞人工智能(ImmuCellAI):一种用于全面预测T细胞亚群丰度的独特方法及其在癌症免疫治疗中的应用。
Adv Sci (Weinh). 2020 Feb 11;7(7):1902880. doi: 10.1002/advs.201902880. eCollection 2020 Apr.
4
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.利用全基因组测序技术对 2658 个人类癌症中的染色体重排进行全面分析。
Nat Genet. 2020 Mar;52(3):331-341. doi: 10.1038/s41588-019-0576-7. Epub 2020 Feb 5.
5
Comprehensive T cell repertoire characterization of non-small cell lung cancer.非小细胞肺癌的全面 T 细胞受体谱特征。
Nat Commun. 2020 Jan 30;11(1):603. doi: 10.1038/s41467-019-14273-0.
6
Genomic and immune profiling of pre-invasive lung adenocarcinoma.肺浸润前腺癌的基因组和免疫特征分析。
Nat Commun. 2019 Nov 29;10(1):5472. doi: 10.1038/s41467-019-13460-3.
7
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.DNA 甲基化缺失促进具有高突变和拷贝数负荷的肿瘤的免疫逃逸。
Nat Commun. 2019 Sep 19;10(1):4278. doi: 10.1038/s41467-019-12159-9.
8
CD8 cytotoxic and FoxP3 regulatory T lymphocytes serve as prognostic factors in breast cancer.CD8细胞毒性T淋巴细胞和FoxP3调节性T淋巴细胞是乳腺癌的预后因素。
Am J Transl Res. 2019 Aug 15;11(8):5039-5053. eCollection 2019.
9
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.多区域外显子组测序揭示了从癌前病变到肺腺癌的基因组进化。
Nat Commun. 2019 Jul 5;10(1):2978. doi: 10.1038/s41467-019-10877-8.
10
Lamina Associated Domains and Gene Regulation in Development and Cancer.层粘连蛋白相关结构域与发育和癌症中的基因调控。
Cells. 2019 Mar 21;8(3):271. doi: 10.3390/cells8030271.